Your browser doesn't support javascript.
loading
Discovery and validation of a prognostic proteomic signature for tuberculosis progression: A prospective cohort study.
Penn-Nicholson, Adam; Hraha, Thomas; Thompson, Ethan G; Sterling, David; Mbandi, Stanley Kimbung; Wall, Kirsten M; Fisher, Michelle; Suliman, Sara; Shankar, Smitha; Hanekom, Willem A; Janjic, Nebojsa; Hatherill, Mark; Kaufmann, Stefan H E; Sutherland, Jayne; Walzl, Gerhard; De Groote, Mary Ann; Ochsner, Urs; Zak, Daniel E; Scriba, Thomas J.
Afiliación
  • Penn-Nicholson A; South African Tuberculosis Vaccine Initiative, Division of Immunology, Department of Pathology and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
  • Hraha T; SomaLogic, Inc., Boulder, Colorado, United States of America.
  • Thompson EG; Center for Infectious Disease Research, Seattle, Washington, United States of America.
  • Sterling D; SomaLogic, Inc., Boulder, Colorado, United States of America.
  • Mbandi SK; South African Tuberculosis Vaccine Initiative, Division of Immunology, Department of Pathology and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
  • Wall KM; SomaLogic, Inc., Boulder, Colorado, United States of America.
  • Fisher M; South African Tuberculosis Vaccine Initiative, Division of Immunology, Department of Pathology and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
  • Suliman S; South African Tuberculosis Vaccine Initiative, Division of Immunology, Department of Pathology and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
  • Shankar S; Center for Infectious Disease Research, Seattle, Washington, United States of America.
  • Hanekom WA; South African Tuberculosis Vaccine Initiative, Division of Immunology, Department of Pathology and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
  • Janjic N; SomaLogic, Inc., Boulder, Colorado, United States of America.
  • Hatherill M; South African Tuberculosis Vaccine Initiative, Division of Immunology, Department of Pathology and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
  • Kaufmann SHE; Max Planck Institute for Infection Biology, Berlin, Germany.
  • Sutherland J; Medical Research Council Unit, The Gambia at the London School of Hygiene and Tropical Medicine, Fajara, The Gambia.
  • Walzl G; DST-NRF Centre of Excellence for Biomedical TB Research and MRC Centre for TB Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, South Africa.
  • De Groote MA; SomaLogic, Inc., Boulder, Colorado, United States of America.
  • Ochsner U; SomaLogic, Inc., Boulder, Colorado, United States of America.
  • Zak DE; Center for Infectious Disease Research, Seattle, Washington, United States of America.
  • Scriba TJ; South African Tuberculosis Vaccine Initiative, Division of Immunology, Department of Pathology and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
PLoS Med ; 16(4): e1002781, 2019 04.
Article en En | MEDLINE | ID: mdl-30990820
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Tuberculosis / Biomarcadores / Proteoma Tipo de estudio: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Child / Female / Humans / Male Idioma: En Revista: PLoS Med Asunto de la revista: MEDICINA Año: 2019 Tipo del documento: Article País de afiliación: Sudáfrica
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Tuberculosis / Biomarcadores / Proteoma Tipo de estudio: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Child / Female / Humans / Male Idioma: En Revista: PLoS Med Asunto de la revista: MEDICINA Año: 2019 Tipo del documento: Article País de afiliación: Sudáfrica